2.69
-0.13(-4.61%)
Currency In USD
| Previous Close | 2.82 |
| Open | 2.56 |
| Day High | 2.78 |
| Day Low | 2.4 |
| 52-Week High | 6.89 |
| 52-Week Low | 0.56 |
| Volume | 993,484 |
| Average Volume | 6M |
| Market Cap | 42.47M |
| PE | -2.69 |
| EPS | -1 |
| Moving Average 50 Days | 2.25 |
| Moving Average 200 Days | 1.28 |
| Change | -0.13 |
If you invested $1000 in iBio, Inc. (IBIO) 10 years ago, it would be worth $0.96 as of March 03, 2026 at a share price of $2.69. Whereas If you bought $1000 worth of iBio, Inc. (IBIO) shares 5 years ago, it would be worth $3.41 as of March 03, 2026 at a share price of $2.69.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
iBio to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
Feb 24, 2026 12:00 PM GMT
SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator of precision antibody therapies, today announced that Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer, and Felipe Duran,
iBio Announces $26 Million Private Placement
GlobeNewswire Inc.
Jan 09, 2026 12:00 PM GMT
SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that it has entered into a securities purchase agreement with existing healthcare-focused, high-quality i
iBio to Participate in the 8th Annual Evercore Healthcare Conference
GlobeNewswire Inc.
Nov 24, 2025 9:15 PM GMT
SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator of precision antibody therapies, today announced that it will participate in the 8th Annual Evercore Healthcare Conference, taking place December 2–4, 20